Redhill Biopharma Ltd (RDHL)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $3.33M
Last updated: Nov 17, 2026 at 4:19 PM ET
Redhill Biopharma Ltd (RDHL) Stock Chart
Redhill Biopharma (RDHL) has a latest price of $0.35 on Nov 17, 2026. Its price fell 67.3% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 64.4%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $11,920.00 in Oct 2016 and its lowest $0.39 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart RDHL with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RDHL.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 44.3%, and over 6 months it fell 62.3%. The month-end price fell 96.5% over the 3 years through Oct 2026, a compound annual decline of 67.3%.
| Period | Change |
|---|---|
| 1 month | -30.2% |
| 3 months | -44.3% |
| 6 months | -62.3% |
| 12 months | -67.3% |
| 12 months, with dividends | -67.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -96.5% | -67.3% |
| 5 years | -100.0% | -85.2% |
| 10 years | -100.0% | -64.4% |
Price by Year
Its best calendar year was 2020, when the price rose 33.1%, and its weakest was 2022, when it fell 94.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.39 | -62.3% |
| 2025 | $1.03 | -83.4% |
| 2024 | $6.21 | -83.0% |
| 2023 | $36.50 | -74.0% |
| 2022 | $140.30 | -94.6% |
| 2021 | $2,580.00 | -68.1% |
| 2020 | $8,080.00 | +33.1% |
| 2019 | $6,070.00 | +9.4% |
| 2018 | $5,550.00 | +8.0% |
| 2017 | $5,140.00 | -50.9% |
Trading Range
The price is 27.7% below its 50-day average of $0.48 and 53.7% below its 200-day average of $0.76.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.35 | |
| 50-day average | $0.48 | -27.7% |
| 200-day average | $0.76 | -53.7% |
Price Risk
Over 3 years, its largest fall from a peak was 99.5%.
| Measure | Value |
|---|---|
| 1-year beta | 0.49 |
| Largest fall, 1 year | -75.0% |
| Largest fall, 3 years | -99.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About RDHL
What is RDHL's 1-year price change?
Redhill Biopharma's price fell 67.3% over the past 12 months. With dividends included, the 12-month total return was -67.3%.
What is RDHL's 5-year price change?
Redhill Biopharma's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 85.2%. These figures leave out dividends.
What is RDHL's beta?
Redhill Biopharma's 1-year beta against the S&P 500 is 0.49, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 75.0%.
Is the RDHL chart free?
Yes. Advanced Charting for RDHL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
RDHL pages: Overview, Charting, Financials, Government Contracts